The gain of a selective advantage in cancer as well as the establishment
of complex traits during evolution require multiple genetic alterations, but how
these mutations accumulate over time is currently unclear. There is increasing
evidence that a mutator phenotype perpetuates the development of many human
cancers. While in some cases, the increased mutation rate is the result of a
genetic disruption of DNA repair and replication or environmental exposures,
other evidence suggests that endogenous DNA damage induced by AID/APOBEC
cytidine deaminases can result in transient localized hypermutation generating
simultaneous, closely-spaced (i.e. “clustered”) multiple
mutations. Here, we discuss mechanisms that lead to mutation cluster formation,
the biological consequences of their formation in cancer and evidence suggesting
that APOBEC mutagenesis can also occur genome-wide. This raises the possibility
that dysregulation of these enzymes may enable rapid malignant transformation by
increasing mutation rates without the loss of fitness associated with permanent
mutators.